89 related articles for article (PubMed ID: 3500028)
1. 1,6-Dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido(1,2-a)- pyrimidine-3-carboxamide (Ch-127) protects against the intestinal damage in rats caused by two weeks' daily administration of indomethacin.
Knoll J; Gyires K; Hermecz I
Drugs Exp Clin Res; 1987; 13(5):253-8. PubMed ID: 3500028
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of prostacyclin and thromboxane A2 by rat gastric mucosa. Comparison of 1,6-dimethyl-4-oxo-1,6,7,8,9,9a-hexahydro-4H-pyrido (1,1-a)-pyrimidine-3-carboxamide and cimetidine.
Rózsa I; Kapui Z; Szécsi T; Hermecz I; Blaskó G
Arzneimittelforschung; 1989 Jun; 39(6):686-9. PubMed ID: 2673252
[TBL] [Abstract][Full Text] [Related]
3. The mechanism of cytoprotective effect of CHINOIN-127.
Kapui Z; Boér K; Hermecz I; Gyíres K
Acta Physiol Hung; 1992; 80(1-4):237-45. PubMed ID: 1345193
[TBL] [Abstract][Full Text] [Related]
4. Effects on immune reactions of non-steroidal anti-inflammatory drugs and of two new pyrido-pyrimidine derivatives (CHINOIN 127 and CHINOIN 105).
Kalmár L; Láng I; Gonzelez-Cabello P; Gergely P; Fehér J
Acta Med Hung; 1986; 43(3):255-63. PubMed ID: 3295745
[TBL] [Abstract][Full Text] [Related]
5. Preventive effect of PGI2, 7-oxo-PGI2 and 17-aza-PGF2 alpha derivate on the development of indomethacin-induced intestinal mucosal damage in rats.
Garamszegi M; Beró T; Jávor T; Mózsik G
Acta Physiol Hung; 1984; 64(3-4):349-53. PubMed ID: 6397968
[TBL] [Abstract][Full Text] [Related]
6. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent.
Watanabe T; Higuchi K; Kobata A; Nishio H; Tanigawa T; Shiba M; Tominaga K; Fujiwara Y; Oshitani N; Asahara T; Nomoto K; Takeuchi K; Arakawa T
Gut; 2008 Feb; 57(2):181-7. PubMed ID: 17639086
[TBL] [Abstract][Full Text] [Related]
7. Intestinal protection by lafutidine, a histamine H(2)-receptor antagonist, against indomethacin-induced damage in rats--role of endogenous nitric oxide.
Tanaka A; Mizoguchi H; Hase S; Miyazawa T; Takeuchi K
Med Sci Monit; 2001; 7(5):869-77. PubMed ID: 11535926
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and gastroprotective activity of 4H-pyrido[1,2-a]pyrimidin-4-ones.
Hermecz I; Sipos J; Vasvári-Debreczy L; Gyires K; Kapui Z
Acta Physiol Hung; 1992; 80(1-4):225-35. PubMed ID: 1345191
[TBL] [Abstract][Full Text] [Related]
9. Dopamine-induced protection against indomethacin-evoked intestinal lesions in rats--role of anti-intestinal motility mediated by D2 receptors.
Miyazawa T; Matsumoto M; Kato S; Takeuchi K
Med Sci Monit; 2003 Feb; 9(2):BR71-7. PubMed ID: 12601282
[TBL] [Abstract][Full Text] [Related]
10. Oral glutamine attenuates indomethacin-induced small intestinal damage.
Basivireddy J; Jacob M; Balasubramanian KA
Clin Sci (Lond); 2004 Sep; 107(3):281-9. PubMed ID: 15128285
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal cytoprotection by indomethacin + sodium salicylate combination in rat.
Ezer E; Matuz J; Pallagi K; Szporny L
Acta Physiol Hung; 1984; 64(3-4):355-9. PubMed ID: 6532123
[TBL] [Abstract][Full Text] [Related]
12. Dual action of nitric oxide in pathogenesis of indomethacin-induced small intestinal ulceration in rats.
Tanaka A; Kunikata T; Mizoguchi H; Kato S; Takeuchi K
J Physiol Pharmacol; 1999 Sep; 50(3):405-17. PubMed ID: 10574470
[TBL] [Abstract][Full Text] [Related]
13. Rofecoxib produces intestinal but not gastric damage in the presence of a low dose of indomethacin in rats.
Yokota A; Taniguchi M; Takahira Y; Tanaka A; Takeuchi K
J Pharmacol Exp Ther; 2005 Jul; 314(1):302-9. PubMed ID: 15831440
[TBL] [Abstract][Full Text] [Related]
14. Role of dietary fibres, intestinal hypermotility and leukotrienes in the pathogenesis of NSAID-induced small intestinal ulcers in cats.
Satoh H; Shiotani S; Otsuka N; Hatao K; Nishimura S
Gut; 2009 Dec; 58(12):1590-6. PubMed ID: 19060018
[TBL] [Abstract][Full Text] [Related]
15. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability.
Playford RJ; MacDonald CE; Calnan DP; Floyd DN; Podas T; Johnson W; Wicks AC; Bashir O; Marchbank T
Clin Sci (Lond); 2001 Jun; 100(6):627-33. PubMed ID: 11352778
[TBL] [Abstract][Full Text] [Related]
16. Sodium-salicylate in contrast with acetylsalicylic acid prevents gastric antral and intestinal ulcers produced by indomethacin in the refed rat.
Ezer E
Acta Physiol Hung; 1985; 65(3):263-6. PubMed ID: 4013765
[TBL] [Abstract][Full Text] [Related]
17. Exacerbation of indomethacin-induced small intestinal injuries in Reg I-knockout mice.
Imaoka H; Ishihara S; Kazumori H; Kadowaki Y; Aziz MM; Rahman FB; Ose T; Fukuhara H; Takasawa S; Kinoshita Y
Am J Physiol Gastrointest Liver Physiol; 2010 Aug; 299(2):G311-9. PubMed ID: 20508157
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic effect of irsogladine maleate against indomethacin-induced small intestinal lesions in rats.
Kamei K; Kubo Y; Kato N; Hatazawa R; Amagase K; Takeuchi K
Dig Dis Sci; 2008 Oct; 53(10):2657-66. PubMed ID: 18306037
[TBL] [Abstract][Full Text] [Related]
19. Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats.
Schmassmann A; Peskar BM; Stettler C; Netzer P; Stroff T; Flogerzi B; Halter F
Br J Pharmacol; 1998 Mar; 123(5):795-804. PubMed ID: 9535006
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the analgesic and anti-inflammatory effects of rimazolium, a pyrido-pyrimidine derivative, compared with that of prostaglandin synthesis inhibitors and morphine.
Gyires K; Fürst S; Miklya I; Budavari I; Knoll J
Drugs Exp Clin Res; 1985; 11(8):493-500. PubMed ID: 3879753
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
